Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 7521 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Apollomics, Inc.

Arvinas to Participate in Upcoming Investor Conferences

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Arvinas, Inc.

The Joint Corp. to Participate in the 36th Annual Roth Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Zevra Therapeutics, Inc.

Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Y-mAbs Therapeutics Inc.

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Jasper Therapeutics, Inc

Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Arcutis Biotherapeutics, Inc.

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: CytomX Therapeutics, Inc.

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Belite Bio, Inc

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: vTv Therapeutics Inc.

NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: NKGen Biotech, Inc.

Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Quoin Pharmaceuticals Ltd.

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Bioventus LLC

First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: First Wave BioPharma, Inc.

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Aclarion

Immuneering to Participate in the Cowen 44th Annual Health Care Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Immuneering Corporation

CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: CymaBay Therapeutics, Inc.

Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Osmol Therapeutics, Inc.

Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Ventyx Biosciences, Inc.

Vor Bio to Participate in Upcoming Investor Conferences

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Vor BioPharma, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑